TKNO
Alpha Teknova Inc
$
4.780
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
4.815
Open
4.420
VWAP
4.67
Vol
188.63K
Mkt Cap
255.80M
Low
4.340
Amount
880.86K
EV/EBITDA(TTM)
--
Total Shares
40.82M
EV
225.03M
EV/OCF(TTM)
--
P/S(TTM)
6.01
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
10.35M
+8.11%
--
--
10.07M
+8.67%
--
--
10.75M
+9.77%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Alpha Teknova, Inc. (TKNO) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -29.08%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-29.08%
In Past 3 Month
4 Analyst Rating
88.28% Upside
Wall Street analysts forecast TKNO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TKNO is 9.00 USD with a low forecast of 8.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
88.28% Upside
Current: 4.780
Low
8.00
Averages
9.00
High
10.00
88.28% Upside
Current: 4.780
Low
8.00
Averages
9.00
High
10.00
Stephens
Stephens
maintain
$8
2025-07-21
Reason
Stephens
Stephens
Price Target
$8
2025-07-21
maintain
Reason
Stephens resumed coverage of Alpha Teknova with an Overweight rating and $8 price target. The company will benefit from growth in the biologics end market, the analyst tells investors in a research note. The firm believes Alpha continues to add to its clinical solutions customer base, which should drive revenue growth as demand ramps.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Alpha Teknova Inc (TKNO.O) is -10.64, compared to its 5-year average forward P/E of -11.62. For a more detailed relative valuation and DCF analysis to assess Alpha Teknova Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-11.62
Current PE
-10.64
Overvalued PE
-0.08
Undervalued PE
-23.16
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-19.18
Current EV/EBITDA
-28.10
Overvalued EV/EBITDA
-1.95
Undervalued EV/EBITDA
-36.42
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
6.48
Current PS
5.21
Overvalued PS
11.22
Undervalued PS
1.75
Financials
Annual
Quarterly
FY2025Q2
YoY :
+7.00%
10.29M
Total Revenue
FY2025Q2
YoY :
-33.61%
-3.39M
Operating Profit
FY2025Q2
YoY :
-33.45%
-3.57M
Net Income after Tax
FY2025Q2
YoY :
-46.15%
-0.07
EPS - Diluted
FY2025Q2
YoY :
-21.84%
-2.31M
Free Cash Flow
FY2025Q2
YoY :
+37.28%
35.94
Gross Profit Margin - %
FY2025Q2
YoY :
-48.11%
-27.00
FCF Margin - %
FY2025Q2
YoY :
-37.80%
-34.70
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
40.5K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
65.0K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
40.5K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
TKNO News & Events
Events Timeline
2025-03-19 (ET)
2025-03-19
08:03:42
Alpha Teknova, Pluristyx launch proprietary PluriFreeze cryopreservation system
2025-03-11 (ET)
2025-03-11
19:02:32
Teknova, Pluristyx announce collaboration over next-generation cell therapies
2025-03-04 (ET)
2025-03-04
16:30:05
Alpha Teknova sees FY25 revenue f $39M -$42M, consensus $41.75M
Sign Up For More Events
Sign Up For More Events
News
9.5
08-07NASDAQ.COMAlpha Teknova (TKNO) Q2 Revenue Jumps 7%
9.5
05-08Yahoo FinanceTeknova Reports First Quarter 2025 Financial Results
9.5
04-24NewsfilterTeknova to Report First Quarter 2025 Financial Results on May 8, 2025
Sign Up For More News
People Also Watch
ZVRA
Zevra Therapeutics Inc
11.760
USD
+0.51%
PERI
Perion Network Ltd
9.180
USD
-0.11%
ITIC
Investors Title Co
239.000
USD
+3.92%
AHG
Akso Health Group
1.860
USD
+7.51%
SNDA
Sonida Senior Living Inc
25.500
USD
+3.41%
ORKA
Oruka Therapeutics Inc
13.950
USD
+6.90%
YRD
Yiren Digital Ltd
5.840
USD
+2.82%
RWAY
Runway Growth Finance Corp
11.100
USD
+1.28%
ACTG
Acacia Research Corp
3.340
USD
+1.52%
FAQ
What is Alpha Teknova Inc (TKNO) stock price today?
The current price of TKNO is 4.78 USD — it has increased 8.39 % in the last trading day.
What is Alpha Teknova Inc (TKNO)'s business?
What is the price predicton of TKNO Stock?
What is Alpha Teknova Inc (TKNO)'s revenue for the last quarter?
What is Alpha Teknova Inc (TKNO)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Alpha Teknova Inc (TKNO)'s fundamentals?
How many employees does Alpha Teknova Inc (TKNO). have?